title: Severe persistent visual field constriction associated with vigabatrin. Patients taking vigabatrin should have regular visual field testing.
authors.forename: N
authors.initials: N
authors.lastname: Blackwell
authors.forename: J
authors.initials: J
authors.lastname: Hayllar
authors.forename: G
authors.initials: G
authors.lastname: Kelly
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D006801:Humans; D008297:Male; D020888:Vigabatrin; D014786:Vision Disorders / Q000139:chemically induced; D014787:Vision Tests; D014794:Visual Fields; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin